20% and 15% success or discount? If it's the success liklihood of these I do wonder where they get these numbers from. Perhaps they dont realise Neuren has already had a successful Phase 2 in both.
Considering the average Phase 3 to Approval success rate is over 60% for all drugs, why would they believe NNZ-2591 needs 3x the normal discount?
NEU Price at posting:
$13.03 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)